ISOO 2022: Dr. Kim Presents Phase 2 SC AU-011 Data

A Phase 2 Trial of belzupacap sarotalocan (AU-011), a First-in-class Targeted Therapy for Choroidal Melanoma via Suprachoroidal (SC) Administration